Generally, GLP-1 injections suit adults with a BMI of 27 or higher, especially when excess weight contributes to conditions like high blood pressure or type 2 diabetes
Communicate with your prescriber and pharmacist they would rather adjust your titration than have you quit
Rationale for GLP-1RA Use in Alzheimers Disease Neuroinflammation and neuroimmune dysfunction are increasingly recognized as key contributors to AD pathophysiology, particularly in early disease stages
Morizane S, Yamasaki K, Mhleisen B, et al
Some providers explore microdosing tirzepatide because its broader mechanism may allow for enhanced benefits at lower doses
For a wider three-way look at the incretin candidates, see our mazdutide vs tirzepatide vs retatrutide comparison